Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Biora Therapeutics, Inc. PROG

Full chart Compare
Set alert

Price alert · PROG

All alert types
0.88 0.00 (+0.00%)

At closeMay 9, 2022, 12:00 AM EDT

0.84 Day range 0.92

52-week range unavailable

Financial health

Altman Z-Score

-19.81 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2018: -2.7×FY 2019: -2.4×FY 2020: -0.8×FY 2021: -0.3×
FY 2018 5y median -1.6× FY 2021
P/S 46.1×
FY 2018: 2.8×FY 2019: 2.5×FY 2020: 2.0×FY 2021: 46.1×
FY 2018 5y median 2.6× FY 2021
P/B -0.7×
FY 2018: -9.6×FY 2019: -4.2×FY 2020: -1.4×FY 2021: -0.7×
FY 2018 5y median -2.8× FY 2021
P/FCF -0.3×
FY 2018: -5.1×FY 2019: -3.2×FY 2020: -0.9×FY 2021: -0.3×
FY 2018 5y median -2.0× FY 2021
EV/EBITDA 0.2×
FY 2018: -3.5×FY 2019: -3.0×FY 2020: -1.1×FY 2021: 0.2×
FY 2018 5y median -2.0× FY 2021
EV/Sales -24.8×
FY 2018: 2.9×FY 2019: 2.7×FY 2020: 2.9×FY 2021: -24.8×
FY 2018 5y median 2.8× FY 2021
FCF Yield -292.8%
FY 2018: -19.8%FY 2019: -31.1%FY 2020: -116.8%FY 2021: -292.8%
FY 2018 5y median -73.9% FY 2021

Profitability

Gross Margin 100.0%
FY 2018: 28.1%FY 2019: 30.2%FY 2020: -25.7%FY 2021: 100.0%
FY 2018 5y median 29.1% FY 2021
Operating Margin -18836.8%
FY 2018: -89.3%FY 2019: -97.3%FY 2020: -262.7%FY 2021: -18836.8%
FY 2018 5y median -180.0% FY 2021
Net Margin -14316.0%
FY 2018: -100.9%FY 2019: -102.8%FY 2020: -259.1%FY 2021: -14316.0%
FY 2018 5y median -180.9% FY 2021
ROE 210.1%
FY 2018: 349.2%FY 2019: 176.5%FY 2020: 179.9%FY 2021: 210.1%
FY 2018 5y median 195.0% FY 2021
ROIC -497.0%
FY 2018: -296.2%FY 2019: -8550.2%FY 2020: -198.3%FY 2021: -497.0%
FY 2018 5y median -396.6% FY 2021
ROA -164.0%
FY 2018: -110.9%FY 2019: -145.5%FY 2020: -124.7%FY 2021: -164.0%
FY 2018 5y median -135.1% FY 2021

Growth (YoY)

Revenue -98.3%
FY 2018: 0.0%FY 2019: 12.5%FY 2020: -48.4%FY 2021: -98.3%
FY 2018 FY 2021
Operating Income -20.3%
FY 2018: 0.0%FY 2019: -22.7%FY 2020: -39.3%FY 2021: -20.3%
FY 2018 FY 2021
EPS (diluted) 7.3%
FY 2018: 0.0%FY 2019: -14.6%FY 2020: -27.5%FY 2021: 7.3%
FY 2018 FY 2021
Free Cash Flow 1.4%
FY 2018: 0.0%FY 2019: -57.0%FY 2020: -55.4%FY 2021: 1.4%
FY 2018 FY 2021

Financial Health

Current Ratio 1.6×
FY 2018: 1.1×FY 2019: 0.7×FY 2020: 1.7×FY 2021: 1.6×
FY 2018 5y median 1.4× FY 2021
Quick Ratio 1.6×
FY 2018: 1.0×FY 2019: 0.6×FY 2020: 1.6×FY 2021: 1.6×
FY 2018 5y median 1.3× FY 2021
Debt / Equity 0.0×
FY 2018: -1.9×FY 2019: -0.9×FY 2020: -1.5×FY 2021: 0.0×
FY 2018 5y median -1.2× FY 2021
Net Debt / EBITDA 0.5×
FY 2018: -0.2×FY 2019: -0.3×FY 2020: -0.4×FY 2021: 0.5×
FY 2018 5y median -0.2× FY 2021
Interest Coverage -18.6×
FY 2018: -12.6×FY 2019: -15.2×FY 2020: -5.6×FY 2021: -18.6×
FY 2018 5y median -13.9× FY 2021

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31